Technology
Health
Biotechnology

HTG Molecular

$2.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (3.60%) Today
+$0.01 (0.43%) After Hours

Why Robinhood?

You can buy or sell HTG Molecular and other stocks, options, ETFs, and crypto commission-free!

About

HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. Its customers include biopharmaceutical companies, academic research centers, and molecular testing laboratories. Read More The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.

Employees
107
Headquarters
Tucson, Arizona
Founded
1997
Market Cap
65.82M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
422.46K
High Today
$2.37
Low Today
$2.22
Open Price
$2.23
Volume
56.05K
52 Week High
$5.46
52 Week Low
$2.03

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
2015 IPO
US
North America

News

Seeking AlphaMay 9

HTG Molecular Diagnostics, Inc. CEO John Lubniewski on Q1 2019 Results - Earnings Call Transcript

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Q1 2019 Earnings Conference Call May 9, 2019 4:30 PM ET Company Participants Monique Kosse - Investor Relations John Lubniewski - Chief Executive Officer Shaun McMeans - Chief Financial Officer Conference Call Participants Jordan Abrams - Cantor Fitzgerald David Delahunt - SVB Leerink Operator Good day and welcome to the HTG Molecular Diagnostics Inc. First Quarter 2019 Earnings Conference Call. Today’s conference is being recorded. At this time, I wou...

56
Yahoo FinanceMay 9

HTG Molecular Diagnostics, Inc. Reports Q1 Loss, Tops Revenue Estimates

HTG Molecular Diagnostics, Inc. (HTGM) delivered earnings and revenue surprises of -11.76% and 15.84%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock? HTG Molecular Diagnostics, Inc. (HTGM) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.22 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surp...

15
Yahoo FinanceMay 9

HTG Molecular Diagnostics Reports First Quarter 2019 Results

Call scheduled for today, May 9, at 4:30pm ET TUCSON, Ariz., May 09, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today reported its financial results for the first quarter ended March 31, 2019. Recent Accomplishments & Highlights: Achieved product and product-related services revenue of $2.7 million for the three months ended March 31, 2019, which represents a 54% increase over the same period in 2018 and re...

63

Earnings

-$0.52
-$0.37
-$0.22
-$0.07
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 6, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.